Le Lézard
Classified in: Health
Subjects: PER, MAT

Aesthetics Biomedical® Names World Renowned Experts To Prestigious Scientific Advisory Board


PHOENIX, July 6, 2020 /PRNewswire-PRWeb/ -- The innovators at Aesthetics Biomedical® (ABM), a leading aesthetics device and product development corporation are honored and excited to announce that Drs. Wendy Roberts, Zoe Draelos, Robert Kellar, Vivian Bucay, and Emil Tanghetti have been appointed to the company's Scientific Advisory Board (SAB).

The goal of the SAB is to collaborate with the most trusted plastic surgeons, dermatologists, and biomedical device and skincare treatment experts to provide scientific research and input into the company's new product development, experience offerings, and clinical study design and execution. Collectively they contribute to advise ABM's senior leadership team on all aspects of the company's clinical operations and product development.

Lawrence Rheins PhD, ABM's Chief Scientific Officer states, "Its critical to have these expert advisors, who are key opinion leaders in their fields, to keep the company focused on its core technology and principles of driving research-based innovation, and provide support to our clinical/scientific team with direct access to clinicians, academicians, and industry veterans."

"As innovators, we value the input and expertise of the experienced physicians working with patients on a daily basis. We have meticulously selected this impressive team for our Scientific Advisory Board to continue to establish ABM's leadership within the field of aesthetics" says MaryAnn Guerra, CEO of Aesthetics Biomedical®.

Each of these individuals bring tremendous talent and expertise to Aesthetics Biomedical's Scientific Advisory Board:

Wendy Roberts, MD ? Dr. Wendy Roberts is a double board-certified dermatologist and the Founding Director of Dermatopathology of Loma Linda Division of Dermatology. She pioneered and developed Generational Dermatologytm which is a detailed system of age management. Dr. Roberts recent achievements include being the Physician Expert for season 1 of Chasing the Cure Live with Ann Curry, earning a spot on the cover of Dermatologist in October 2019, Moderator and Author of JDD Supplement Practical Applications for Medical and Aesthetic Treatment of Skin Of Color, and being the first and only female dermatologist to exclusively own her own meeting.

Zoe Draelos, MD ? Dr. Zoe Draelos is a research and clinical board-certified dermatologist. She has a solo private practice in North Carolina and is the founder of Dermatology Consulting Services, PLLC. Dr. Draelos was elected Vice President of the American Academy of Dermatology. In addition to the 3rd edition of her Cosmetic Dermatology textbook currently under preparation, Dr. Draelos' recent achievements include the Society of Cosmetic Chemists awarding her both the 2018 Maison de Nevarre award given to an individual who has contributed greatly through research for the advancement of Cosmetic Science followed by the inaugural Florence Wall Award in 2019 given to the most influential woman in Cosmetic Science.

Robert Kellar PhD ? Dr. Robert Kellar is Founder and President of Development Engineering Sciences, LLC. He has over 19 years of experience in the development and regulatory approval of medical devices, cell-based products and tissue engineering. A PhD in Physiological Sciences from the Univ of AZ, he has served on multiple Scientific Advisory Boards in regenerative medicine. Recent accomplishments include 145 scientific abstracts, 35 peer-reviewed publications, and 6 issued US patents. As well as being awarded Arizona Business Magazine's Healthcare 2019 Leaders Award, and the 2020 Research and Creative Activity (RCA), Northern Arizona University, "Most Significant Innovation in Technology Transfer of Commercialization" award.

Vivian Bucay, MD ? Dr. Vivian Bucay completed her dermatology training at the University of Miami and the Baylor College of Medicine. She serves as volunteer faculty as Clinical Assistant Professor in the Department of Physician Assistant studies at the University of Texas Health Science Center and is faculty on several other continuing medical education initiatives in the US. In addition to lecturing nationally and internationally, and publishing papers in peer reviewed journals and writing book chapters for dermatology textbooks and publications. Dr. Bucay has also been recognized as a Texas Super Doctor yearly since 2004. She recognizes one of her greatest achievements, aside from her daughters, is surviving stage 4 melanoma in 2006-7.

Emil Tanghetti, MD ? Dr. Emil Tanghetti graduated first in his class and received the Dean Warren medal for academic excellence. He is a fellow of the American Society for Laser Medicine and Surgery, and a member of the California Medical Association, the American Medical Association, and the American Academy of Dermatology. In just the last year, Dr. Tanghetti has had 13 articles published on topics including Rosacea, Acne, Psoriasis, and energy-based therapies. He's also recently been invited to join Lasers in Surgery and Medicine as an associate editor, as well as editor for a special 2020 dermatology issue.

SAB members will also represent Aesthetics Biomedical® at industry events, conferences, drafting of scientific papers and participate in clinical trials.

ABOUT AESTHETICS BIOMEDICAL®: The aesthetic innovation company headquartered in Phoenix, Ariz., uniquely offering procedure and product enhancement, development, clinical indication, expansion, application optimization, FDA clearance expertise and worldwide distribution. Aesthetics Biomedical's innovation center is a leader in breakthrough technologies and multiple source combination therapies for its clients, physician network and the aesthetic arena.

CONTACTS:
Marketing Contact: Sheldon Larson, CMO
[email protected]

Press Contact: Courtney Frappier, Senior PR Manager
[email protected]

 

SOURCE Aesthetics Biomedical


These press releases may also interest you

at 05:04
Sirnaomics Ltd. (the "Company"; together with its subsidiaries, "Sirnaomics" or the "Group"; stock code: 2257), a leading biopharmaceutical company engaged in the discovery and development of advanced RNAi therapeutics, has announced its audited...

at 04:28
GymNation, the homegrown UAE fitness brand, has today announced that due to unprecedented growth, it is reaching capacity across its 12 UAE gym locations and diversifying into a new market, brewing up a storm with the launch of its first-ever branded...

at 04:00
Cancer spreads from its primary tumor to other parts of the body via blood or the lymphatic system in a process termed 'metastasis'. This usually represents an advanced stage in the disease's progression and tends to be fatal. Therefore, preventing...

at 03:30
Vicore Pharma Holding (STO:VICO)Sessions at ATS to include an oral late-breaking presentation of the final results from the Phase 2a AIR trial of buloxibutid (C21) in IPFAdditional presentations include preclinical and translational data reflecting...

at 03:13
Orexo's Annual and Sustainability Report for 2023 has been published and can be downloaded at, www.orexo.com. The Swedish version of the Report is also available on the company's website in European Single Electronic Format (ESEF). A PDF version is...

at 03:05
Surge has just closed its second round of funding, raising ?7.5 million. The round was led by Eurazeo with the participation of Kima, Teampact, and MH Innov', as well as the support of historical funds Boutique Venture, HCVC, and 50 Partners Santé....



News published on and distributed by: